Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Onconova Therapeutics for $135,546.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA103571-01A1 | Phase I | 135,546 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS045418-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA101346-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $275,861.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA156929-01 | Phase I | 275,861 | ||||||||
A SBIR Phase II contract was awarded to Onconova Therapeutics for $845,883.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS045418-02 | Phase II | 845,883 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $218,796.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL085034-01 | Phase I | 218,796 | ||||||||
A STTR Phase I contract was awarded to Onconova Therapeutics for $203,744.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41MH082775-01 | Phase I | 203,744 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $220,180.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA134108-01A1 | Phase I | 220,180 | ||||||||
A SBIR Phase I contract was awarded to Onconova Therapeutics for $155,103.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA128322-01 | Phase I | 155,103 |